Emera Inc
EMA
BCE Inc
BCE
TELUS Corp
T
4
Choice Properties Real Estate Investment Trust
CHP.UN
5
Power Corporation of Canada
POW
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.